Cite
PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1
MLA
Jingjing Xu, et al. “PDIA6 Promotes Pancreatic Cancer Progression and Immune Escape through CSN5-Mediated Deubiquitination of β-Catenin and PD-L1.” Neoplasia: An International Journal for Oncology Research, vol. 23, no. 9, Sept. 2021, pp. 912–28. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1e492ab4c35bf91ab8520d05789938c6&authtype=sso&custid=ns315887.
APA
Jingjing Xu, Zhengyang Wang, Yanan Jiang, Yihui Ma, Lan Zhang, & Peiyi Xia. (2021). PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1. Neoplasia: An International Journal for Oncology Research, 23(9), 912–928.
Chicago
Jingjing Xu, Zhengyang Wang, Yanan Jiang, Yihui Ma, Lan Zhang, and Peiyi Xia. 2021. “PDIA6 Promotes Pancreatic Cancer Progression and Immune Escape through CSN5-Mediated Deubiquitination of β-Catenin and PD-L1.” Neoplasia: An International Journal for Oncology Research 23 (9): 912–28. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1e492ab4c35bf91ab8520d05789938c6&authtype=sso&custid=ns315887.